Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
Casopis Lekaru Ceskych
|
August 24, 1992
[Clinical study of biocompatibility of dialysis membranes made from non-modified and modified cellulose]
K Opatrný, S Sulková, L Vít, et al.
Artificial Organs
|
March 1, 1994
Bacteria- and endotoxin-free dialysis fluid for use in chronic hemodialysis
R Bambauer, J Walther, S Meyer, et al.
The International Journal of Artificial Organs
|
August 1, 1993
Side effects of hybrid liver support therapy: TNF-alpha liberation in pigs, associated with extracorporeal bioreactors
J Gerlach, A Jörres, O Trost, et al.
Kidney & Blood Pressure Research
|
April 4, 2006
Relation between different treatment modalities and genomic damage of end-stage renal failure patients
K Kobras, N Schupp, K Nehrlich, et al.
Journal of Biomedical Materials Research
|
May 1, 1996
Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes
B M Matata, J M Courtney, S Sundaram, et al.
Biomaterials
|
November 1, 1995
In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents
B M Matata, S Wark, S Sundaram, et al.
Transplantation Proceedings
|
March 20, 2003
Increased expression of P21((WAF1/CIP1)) CDKI gene in chronic allograft nephropathy correlating with the number of acute rejection episodes
A B Chkhotua, A Altimari, E Gabusi, et al.
The International Journal of Artificial Organs
|
November 29, 2002
Extracorporeal liver support: porcine or human cell based systems?
J C Gerlach, K Zeilinger, I M Sauer, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
Casopis Lekaru Ceskych
|
August 24, 1992
[Clinical study of biocompatibility of dialysis membranes made from non-modified and modified cellulose]
K Opatrný, S Sulková, L Vít, et al.
Artificial Organs
|
March 1, 1994
Bacteria- and endotoxin-free dialysis fluid for use in chronic hemodialysis
R Bambauer, J Walther, S Meyer, et al.
The International Journal of Artificial Organs
|
August 1, 1993
Side effects of hybrid liver support therapy: TNF-alpha liberation in pigs, associated with extracorporeal bioreactors
J Gerlach, A Jörres, O Trost, et al.
Kidney & Blood Pressure Research
|
April 4, 2006
Relation between different treatment modalities and genomic damage of end-stage renal failure patients
K Kobras, N Schupp, K Nehrlich, et al.
Journal of Biomedical Materials Research
|
May 1, 1996
Determination of contact phase activation by the measurement of the activity of supernatant and membrane surface-adsorbed factor XII (FXII): its relevance as a useful parameter for the in vitro assessment of haemodialysis membranes
B M Matata, J M Courtney, S Sundaram, et al.
Biomaterials
|
November 1, 1995
In vitro contact phase activation with haemodialysis membranes: role of pharmaceutical agents
B M Matata, S Wark, S Sundaram, et al.
Transplantation Proceedings
|
March 20, 2003
Increased expression of P21((WAF1/CIP1)) CDKI gene in chronic allograft nephropathy correlating with the number of acute rejection episodes
A B Chkhotua, A Altimari, E Gabusi, et al.
The International Journal of Artificial Organs
|
November 29, 2002
Extracorporeal liver support: porcine or human cell based systems?
J C Gerlach, K Zeilinger, I M Sauer, et al.
Page
of 8